By Nicholas G. Miller
Shares of Perrigo slipped after the company posted second-quarter earnings and revenue below Wall Street's expectations.
The stock was down 13%, to $23.22, and is down 19% over the last 12 months.
The Irish over-the-counter health products company reported a loss of $8.4 million, or 6 cents a share, compared with a loss of $108.4 million, or 79 cents a share, a year prior.
Adjusted earnings were 57 cents a share. Wall Street expected 59 cents, according to FactSet.
The company reported $1.06 billion in revenue, a tick down from $1.07 billion the prior year. Analysts expected $1.08 billion. Top-line declines were fueled by a 1.9% fall in revenue from the company's Americas division. The company cited "a challenging consumer environment in the U.S. and the EU."
The company reaffirmed its full-year revenue guidance of flat to up 3%, but said it expected the lower end of that guidance, citing slower recovery in the company's infant-formula business and "challenging market consumption."
Write to Nicholas G. Miller at nicholas.miller@wsj.com
(END) Dow Jones Newswires
August 06, 2025 14:20 ET (18:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。